Latest News about AZN
Recent news which mentions AZN
Stocks to own ahead of a rally that this $15 billion fund house says is coming soon
October 25, 2023
From MarketWatch
Why Is LumiraDx (LMDX) Stock Down 35% Today?
October 24, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
October 23, 2023
From Benzinga
Why Is LumiraDx (LMDX) Stock Up 323% Today?
October 23, 2023
From InvestorPlace
Merck Signs Multi-Billion Deal With Japan's Daiichi Sankyo For Cancer Therapy Drug Development
October 20, 2023
From Benzinga
United Airlines, Interactive Brokers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 18, 2023
From Benzinga
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
October 17, 2023
From Benzinga
Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants
October 16, 2023
From Benzinga
Understanding AstraZeneca's Position In Pharmaceuticals Industry Compared To Competitors
October 16, 2023
Tickers
AZN
From Benzinga
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
October 16, 2023
From Benzinga
AstraZeneca's Tagrisso-Chemo Combo Under FDA Priority Review For Most Common Form Of Lung Cancer
October 16, 2023
Tickers
AZN
From Benzinga
From InvestorPlace
ABBV Stock: Buy for the Yield, Hold for This Other Reason
October 13, 2023
From InvestorPlace
2 Nasdaq 100 Stocks That Are Surefire Buys in October, and 1 to Avoid Like the Plague
October 06, 2023
From Motley Fool
Why Shares of Conduit Pharmaceuticals Are Jumping Wednesday
October 04, 2023
From Motley Fool
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
From Benzinga
From Benzinga
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
October 03, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment
September 29, 2023
From MarketWatch
Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst
September 28, 2023
From Benzinga
From Benzinga
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
From Benzinga
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
September 27, 2023
From Benzinga
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
September 27, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
